Is a Beat in the Cards for Gilead (GILD) in Q1 Earnings?
Gilead (GILD) is likely to beat earnings estimates when it reports fi.....»»
Gilead Reports Q1 Earnings Beat, Anticipates Short-Term Impact From Coronavirus
Gilead Sciences (NASDAQ: GILD) reported quarterly earnings of $1.68 per share on Thursday, which beat the analyst consensus estimate of $1.57 by 7.01%. This is a 4.55% decrease over earnings of $1.76 per share from the same period last year. read more.....»»
Gilead Ticks Higher After Q2 Earnings Beat
Gilead Sciences, Inc. (NASDAQ: GILD) shares are slightly higher after reporting a second-quarter earnings beat. read more.....»»
HIV Segment to Aid Gilead (GILD) Beat Q1 Earnings Estimates?
Gilead (GILD) is likely to report an earnings beat in the first-quarter (results due on May 1) driven by its HIV franchise strength. Biotech bigwig Gilead Sciences Inc. GILD develops drugs for the treatment of human immu.....»»
Will HIV Sales Drive Gilead (GILD) to Beat in Q2 Earnings?
Gilead (GILD) is li.....»»
Gilead Sciences, Inc. (GILD) CEO Daniel O"Day on Q3 2019 Results - Earnings Call Transcript
Gilead Sciences, Inc. (GILD) CEO Daniel O"Day on Q3 2019 Results - Earnings Call Transcript.....»»
Earnings Watch: Gilead Sciences stock falls after earnings beat, revenue miss
Gilead Science Inc. shares dropped about 2.5% in the extended session Thursday, after the drug maker beat Wall Street’s earnings expectations but reported lower-than-expected sales......»»
Gilead Sciences, Inc. (GILD) CEO Daniel O"Day on Q2 2019 Results - Earnings Call Transcript
Gilead Sciences, Inc. (GILD) CEO Daniel O"Day on Q2 2019 Results - Earnings Call Transcript.....»»
Gilead earnings show surprising sales increase amid massive change
Gilead Sciences Inc. reported a surprising gain in revenue Tuesday afternoon and beat earnings expectations, sending shares about 2% higher in after-hours trading......»»
Is a Beat in the Cards for FirstEnergy (FE) in Q2 Earnings?
Focus on reliability, resiliency and security through Energizing the Future plan is expected to drive FirstEne.....»»
Is a Beat in the Cards for Centene"s (CNC) Q2 Earnings?
Centene's (CNC) Q2 earnings are likely to be cushioned by higher revenues and membership. .....»»
Ameren (AEE) to Report Q1 Earnings: Is a Beat in the Cards?
Ameren (AEE) continues to implement its strategy of investing in rate-regulated energy infrastructure during the first quarter for improving its ove.....»»
Gilead Sciences Rises on 1st-Quarter Results
Major drug manufacturer beats earnings forecastsRelated Stocks: GILD,.....»»
Is a Beat in the Cards for FLEETCOR (FLT) in Q1 Earnings?
FLEETCOR (FLT) first-quarter 2019 revenues likely to reflect strength across fuel, corporate pa.....»»
Gilead Sciences, Inc. (GILD) CEO Daniel O"Day on Q1 2019 Results - Earnings Call Transcript
Gilead Sciences, Inc. (GILD) CEO Daniel O"Day on Q1 2019 Results - Earnings Call Transcript.....»»
Gilead Sciences (GILD) Q1 Earnings Top Estimates
Gilead (GILD) delivered earnings and revenue surprises of 8.64% and -0.49%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock? Want the latest recommendations from Zack.....»»
Gilead stock rises 1% after earnings beat
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Is a Beat in the Cards for Mallinckrodt (MNK) Q1 Earnings?
Investors are looking forward to the performance of Specialty Brands and other pipeline updates, when Mallinckrodt (MNK) reports Q1 results on May 7. .....»»